Sharon Bola is a global product manager with the process chromatography business group at Bio-Rad Laboratories. She holds a master's degree in pharmacology. Prior to transitioning into her current role, she started her career working in downstream processing groups at major biopharmaceutical companies. She has had hands-on experience in the purification of proteins including monoclonal antibodies (mAbs). She is a content marketer at Bio-Rad and enjoys teaching and understanding customer’s needs.
About this event:
Date: October 7, 2025
Time: 11 am EDT | 8 am PDT | 5 pm CEST
Duration: 15 minutes
Chromatography resins have long been a cornerstone in the purification and analysis of biomolecules, particularly for therapeutic purposes, due to their ability to produce high-yield, high-purity end products. Recent advancements have revealed that these resins possess unique properties that extend beyond their traditional analytical and manufacturing roles, making them suitable for use in therapies administered directly to patients.
This webinar will delve into the innovative use of Bio-Rad Aminex Resins, which are composed of a styrene divinylbenzene copolymer with sulfonic acid functional groups, as strong cation exchangers. These resins have shown significant promise in microsphere-based therapies for clinical applications, including the treatment of human diseases such as cancer.
The discussion will highlight the versatility and effectiveness of these resins, positioning them as valuable tools in the development of cutting-edge medical treatments.
Key Takeaways:
Chromatography resins enable precise drug/radionuclide delivery and retention.
Resins can ensure sustained drug release with minimal toxicity.
.png?width=700&name=New-ATE-Logo2019%20(1).png)
